Sleep

01Key questions

02Sleep Architecture

The Sleep Stages

Swipe table →

Sleep Cycles

• Each cycle lasts ~90 minutes
• Deep sleep dominates early cycles; REM dominates later cycles
• Cutting sleep short primarily sacrifices REM — critical for emotional and cognitive health

NREM Oscillations (2024-2026 framework)

• Slow waves (0.5-4 Hz): the dominant cortical rhythm of N3; the main substrate of "deep sleep" physiology
• Sleep spindles (12-16 Hz): generated in N2; coupled to slow-wave up-states; index of memory consolidation capacity
• Spindle-slow wave coupling correlates with overnight memory consolidation and IQ; deteriorates with age
• K-complexes: evoked cortical isolation events that protect sleep from internal/external stimuli

03What Sleep Does

Physical Restoration

• Immune function: T-cell function peaks during sleep; sleep deprivation reduces vaccine efficacy by 50%
• DNA repair: Cellular repair processes are upregulated during sleep
• Metabolic regulation: Sleep deprivation immediately impairs glucose tolerance and increases hunger hormones

Cognitive Function

• Memory consolidation: Transfer from hippocampus to cortex occurs during sleep; spindle-SWA coupling is the mechanism
• Waste clearance: The glymphatic system clears amyloid-β and tau during deep sleep (literally washing the brain)
• Synaptic pruning: Sleep refines neural connections, removing unnecessary ones
• Learning: You learn during wakefulness but consolidate during sleep

Hormonal Regulation

Swipe table →

04Glymphatic Clearance — The 2024-2026 Update

This section was expanded significantly. The original 2013 Xie/Nedergaard rodent work has now been translated to humans.

The Mechanism

• During deep NREM sleep, brain cells (especially astrocytes) shrink by ~60%, expanding the interstitial space and allowing CSF to flush through perivascular tunnels
• Slow vasomotion (low-frequency vascular oscillations) — driven by drops in norepinephrine — actively pumps CSF through tissue (Hauglund NL et al., Cell, 2025)
• The system clears metabolic waste: amyloid-β, tau, α-synuclein, lactate
• Animal evidence: Xie et al., Science 2013 (PMID 24136970) — sleep increases interstitial space and Aβ clearance vs wake/anesthesia
• Human evidence: Dagum P et al., Nature Communications 2026 — first demonstration that overnight sleep increases plasma Aβ and tau species vs sleep deprivation, interpreted as effective brain-to-blood clearance
• Mechanism paper: Hauglund NL, Nedergaard M et al., Cell 2025 — norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep

Sleep Position (lateral > supine > prone)

• MRI contrast studies in rodents and human simulation (Lee H, Benveniste H, Stony Brook) demonstrate lateral (side) sleep position produces the most efficient glymphatic transport vs supine or prone
• Dementia patients spend significantly more time in supine position than controls — associative, not causal, but mechanistically plausible
• Most humans naturally default to lateral sleep — consistent with optimization
• Practical: if you must sleep supine (e.g., pregnancy, OSA positional therapy), this is not catastrophic — position changes ~11x/night

Aging and Clearance Decline

• Deep NREM sleep (slow-wave activity) declines ~2% per year after age 50; this directly impairs glymphatic clearance
• Late-life slow-wave loss is hypothesized to be a primary driver of Alzheimer's protein aggregation, not just a consequence
• This is why enhancing slow-wave sleep is a therapeutic target (see Acoustic Stimulation section below)

05The Circadian Rhythm System

The Master Clock

• Suprachiasmatic nucleus (SCN): Located in hypothalamus; receives light input via retina
• Light is the primary zeitgeber (time-giver) — morning sunlight sets the clock
• Secondary zeitgebers: Meal timing, exercise, social interaction, temperature
• Every cell has peripheral clocks that need to be synchronized with the master clock

The Melatonin Pathway

Morning sunlight → Retina → SCN → Suppresses melatonin → Cortisol rises → Alertness
Darkness → Retina → SCN → Pineal gland → Melatonin release → Sleep onset

Circadian Disruption Consequences

• Shift workers: 30-50% increased risk of cardiovascular disease, diabetes, cancer
• Night shift is classified as a probable carcinogen by IARC (WHO)
• Social jetlag (weekend schedule shift) measurably impairs metabolic health
• Irregular sleep schedules are as harmful as short sleep duration

06Doses in studies

Light Environment (Most Important)

Swipe table →

Temperature

• Core body temperature must drop 1-2°F to initiate sleep
• Bedroom temperature: 60-67°F (15-19°C) optimal
• Cooling mattress toppers/pads: Chilipad, Eight Sleep — effective for hot sleepers

Timing and Routine

• Consistent schedule: Same bed/wake time ±30 min, including weekends
• No caffeine after 12-2pm: Caffeine half-life is 5-7 hours; quarter-life is 10-12 hours
• No alcohol: Fragments sleep, suppresses REM, impairs glymphatic clearance

Supplements for Sleep

Swipe table →

Critical note on melatonin (2026 update): Most commercial melatonin is massively overdosed (3-10 mg). Physiologic dose is 0.1-0.3 mg (Zhdanova, MIT 2001). High doses can cause receptor downregulation, vivid dreams/nightmares, morning grogginess, daytime hypothermia. Low-dose studies used (0.3-0.5 mg). A 2025 Brain Sciences paper (Valiensi et al., MDPI 15:1040) revisited higher-dose melatonin in aged patients with comorbidities and concluded higher doses (3-5 mg) are well-tolerated and useful in specific clinical contexts (jet lag, shift work, REM Behavior Disorder, oncology adjunct) but should NOT be first-line for general insomnia in younger adults.

07Pharmaceutical Sleep Aids (2025-2026 Landscape)

Dual Orexin Receptor Antagonists (DORAs)

The first mechanistic sleep aids that don't act as sedatives — they block the wake-promoting orexin system, allowing natural sleep to proceed.

Swipe table →

• DORAs preserve sleep architecture (no REM/SWS suppression like benzodiazepines or z-drugs)
• Lower abuse potential, no dependence
• Best evidence for sleep-maintenance insomnia, especially in older adults
• Mechanistic rationale: orexin neurons are hyperactive in insomnia; blocking them reduces wake drive without sedating the cortex

Older Agents — Avoid When Possible

• Zolpidem, eszopiclone, benzodiazepines: suppress deep sleep, suppress REM, impair glymphatic clearance, dependence/tolerance, falls in elderly. Reserve for occasional use; avoid chronic.
• OTC diphenhydramine/doxylamine: anticholinergic, impairs next-day cognition, should not be used chronically — associated with dementia risk in observational data

08Sleep Enhancement Technologies (Emerging, 2025-2026)

Closed-Loop Acoustic Stimulation (CLAS / PTAS)

• Mechanism: EEG headband detects slow-wave up-states; delivers brief tones (50 ms, ~50 dB) phase-locked to the up-state → enhances slow-wave amplitude and coupling
• Evidence:
• Papalambros NA et al., Front Hum Neurosci 2017 — older adults: enhanced SWA + memory improvement
• Van den Bulcke L et al., Am J Geriatr Psychiatry 2025 — CLAS enhanced SWA in mild cognitive impairment (cited 23+ times)
• Parkinson Disease proof-of-concept (medRxiv 2025) — PTAS feasible + tolerated in neurodegeneration
• Smith MT, Reid MJ, Coon WG et al., PMC12914948 (2025) — design notes for next-gen closed-loop neurostimulation; now includes focused ultrasound (fUS) targeting thalamic deep structures noninvasively
• Commercial devices: Dreem 3 headband, SleepLoop, Elemind
• Practical: Promising for aging population seeking to preserve slow-wave sleep; not yet standard-of-care; effects on memory consolidation inconsistent across protocols

Transcranial Direct Current Stimulation (tDCS) / Electrical

• Preliminary evidence for slow-wave enhancement; less mature than CLAS
• Noninvasive impedance spectroscopy for clearance monitoring (Dagum P et al., 2025) — early validation

Temperature-Active Mattresses

• Eight Sleep Pod, Chilipad — active cooling/warming; consistent with thermoregulation data; user-reported improved deep sleep, but RCT evidence limited

09Measuring Sleep Quality

Subjective Markers

• Wake feeling rested (energy within 15 minutes of waking)
• No excessive daytime sleepiness
• No caffeine requirement to function
• Stable mood and cognitive clarity throughout the day

Objective Tracking

Swipe table →

Key Metrics to Track

• Total sleep time: 7-9 hours
• Sleep efficiency: >85% (time asleep / time in bed)
• Deep sleep: 15-25% of total sleep
• REM: 20-25% of total sleep
• HRV: Trending upward over time
• Resting heart rate: Below daytime baseline, trending lower
• Sleep regularity index: more predictive of mortality than total sleep duration (Windred et al., 2023)

10Special Populations

Aging (60+)

• Slow-wave sleep declines ~2%/year after 50; this directly impairs glymphatic clearance
• Melatonin production decreases; lower physiologic dose may be relatively higher dose
• Earlier sleep phase (advanced circadian) is normal; don't fight it
• Acoustic stimulation / CLAS is most promising intervention for this group

Shift Workers

• Cannot fully adapt — fight the underlying physiology, not the schedule
• Strategic light exposure: bright light during shift, blackout during day-sleep
• Caffeine timing: only first half of shift (avoid 6h before sleep)
• Evidence suggests permanent shift work carries non-trivial long-term health risk

Pregnancy

• Side sleeping (especially left lateral) recommended in 2nd/3rd trimester — improves uterine blood flow
• Lateral sleep also improves glymphatic clearance — convergent rationale

What studies and practitioners report

Amounts as reported in the cited sources: trial doses with the population studied, and practitioner-reported ranges marked as such. Not medical advice.

• Trial 250-400 mg · Magnesium bisglycinate not stated in source PMC12412596
• Trial 3 g · Glycine before bed healthy adults under sleep restriction PMID 22529837

Further reading: detailed protocols

• Huberman Lab: toolkit for sleep hubermanlab.com

11Connections

12Sources

1. Xie L et al. (2013). "Sleep Drives Metabolite Clearance from the Adult Brain." Science . PMID 24136970PubMed 24136970
2. Schuster et al. (2025). "Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial." Nature and Science of Sleep . PMC12412596 .PMC12412596
3. Smith MT, Reid MJ, Coon WG et al. (2025). "Acoustic stimulation and other emerging approaches to enhance sleep: design notes for the next generation of closed-loop neurostimulation technology." PMC12914948 — incl. focused ultrasound thalamic targeting.PMC12914948
4. Iliff JJ et al. (2012). "A Paravascular Pathway Facilitates CSF Flow Through the Brain." Sci Transl Med . PMID 22896675PubMed 22896675
5. Spiegel K et al. (1999). "Impact of Sleep Debt on Metabolic and Endocrine Function." Lancet . PMID 10371174PubMed 10371174
6. Burgess HJ et al. (2020). "Sleep, Circadian Rhythms, and Health." PMC7202392PMC7202392
7. Nedergaard M, Goldman SA. (2020). "Glymphatic Failure as a Final Common Pathway to Dementia." Science . PMID 33004513PubMed 33004513
8. Dagum P et al. (2026). "The glymphatic system clears amyloid beta and tau from brain to plasma in humans." Nature Communications . doi 10.1038/s41467-026 — first human demonstration of sleep-dependent brain-to-blood clearance.DOI 10.1038/s41467-026
9. Huang Z, Wang H, Zhang B et al. (2025). "Efficacy and safety of daridorexant in Chinese patients with insomnia disorder: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial." SLEEPJ 48(12):zsaf170. doi 10.1093/sleep/zsaf170 .DOI 10.1093/sleep/zsaf170
10. Lederer K, Benes H, Fine A et al. (2025). "A randomised crossover trial of daridorexant for the treatment of chronic insomnia and nocturia." J Sleep Res 34(6):e70002. doi 10.1111/jsr.70002 .DOI 10.1111/jsr.70002
11. Lopresti AL, Smith SJ (2026). "The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial." Front Nutr 12:1729164. doi 10.3389/fnut.2025.1729164 .DOI 10.3389/fnut.2025.1729164
12. Van den Bulcke L et al. (2025). "Acoustic Stimulation to Improve Slow-Wave Sleep in [MCI]." Am J Geriatr Psychiatry . doi 10.1016/j.jagp.2024.x — CLAS enhances SWA in mild cognitive impairment.DOI 10.1016/j.jagp.2024.x
13. Valiensi SM et al. (2025). "Rethinking Melatonin Dosing: Safety and Efficacy at Higher-than-Usual Levels in Aged Patients with Sleep Disturbances and Comorbidities." Brain Sciences 15(10):1040. doi 10.3390/brainsci15101040 .DOI 10.3390/brainsci15101040

13Entry history

Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.